chr8-60816506-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_017780.4(CHD7):c.2613+5G>A variant causes a splice donor 5th base, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000017 in 1,473,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017780.4 splice_donor_5th_base, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHD7 | NM_017780.4 | c.2613+5G>A | splice_donor_5th_base_variant, intron_variant | ENST00000423902.7 | NP_060250.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.2613+5G>A | splice_donor_5th_base_variant, intron_variant | 5 | NM_017780.4 | ENSP00000392028 | P1 | |||
CHD7 | ENST00000524602.5 | c.1716+35456G>A | intron_variant | 1 | ENSP00000437061 | |||||
CHD7 | ENST00000525508.1 | c.2613+5G>A | splice_donor_5th_base_variant, intron_variant | 5 | ENSP00000436027 | |||||
CHD7 | ENST00000695853.1 | c.2613+5G>A | splice_donor_5th_base_variant, intron_variant, NMD_transcript_variant | ENSP00000512218 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000140 AC: 3AN: 214848Hom.: 0 AF XY: 0.00000866 AC XY: 1AN XY: 115416
GnomAD4 exome AF: 0.0000114 AC: 15AN: 1321292Hom.: 0 Cov.: 20 AF XY: 0.00000604 AC XY: 4AN XY: 662388
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74432
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 5 with or without anosmia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2008 | - - |
CHARGE syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | This sequence change falls in intron 8 of the CHD7 gene. It does not directly change the encoded amino acid sequence of the CHD7 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with hypogonadotropic hypogonadism (PMID: 18834967, 29419413, 34837038). This variant is also known as IVS8+5G>A. ClinVar contains an entry for this variant (Variation ID: 2035). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 8 and introduces a premature termination codon (PMID: 18834967). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Childhood onset hearing loss Uncertain:1
Uncertain significance, criteria provided, single submitter | research | National Institute on Deafness and Communication Disorders, National Institutes of Health | Jul 08, 2021 | PS3_moderate, PP3 / Modifications from PMID: 30311386 for classification: The genetic causes of hearing loss have not yet been well characterized in the Yoruba population, and the information regarding variant MAF in this population is still limited, so we did not exclude any variant based on their "high" MAF. PP3 criteria was applied even if the REVEL score was below 0.7, if at least two of the pathogenicity prediction algorithms used predicted that the variant was damaging or likely damaging. - |
CHARGE syndrome;C3552553:Hypogonadotropic hypogonadism 5 with or without anosmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 13, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 01, 2021 | Observed in multiple unrelated individuals with hypogonadotrophic hypogonadism; the variant was inherited from an unaffected mother in one family, and another family also harbored a frameshift variant in the FGFR1 gene (Kim et al., 2008; Zhang et al., 2019; Cassatella et al., 2018; Xu et al., 2018); Published functional studies confirm variant results in skipping of exon 8, and is predicted to result in a frameshift and subsequent protein truncation (Kim et al., 2008); This variant is associated with the following publications: (PMID: 29144511, 29419413, 18834967) - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at